New FDA Approvals: ASCO Session Reviews Uses and Adverse Effects
What should doctors expect if they prescribe nirogacestat for desmoid tumors? What about fruquintinib for metastatic colorectal cancer (mCRC)? Nirogacestat, marketed as Ogsiveo (Springworks Therapeutics), and fruquintinib, marketed as Fruzaqla (Takeda …